Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Taiwan · Delayed Price · Currency is TWD

10.95

-0.05 (-0.45%)

Oct 8, 2026, 1:30 PM CST

Market Cap	1.30B -32.0%
Revenue (ttm)	514.65M +10.7%
Net Income	3.09M
EPS	0.03
Shares Out	118.74M
PE Ratio	420.36
Forward PE	n/a
Dividend	0.20 (1.83%)
Ex-Dividend Date	Sep 23, 2026

Volume	112,640
Open	10.90
Previous Close	11.00
Day's Range	10.90 - 11.00
52-Week Range	10.35 - 16.90
Beta	-0.05
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1995

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4109

Full Company Profile

Financial Performance

In 2025, Jia Jie Biomedical's revenue was 485.40 million, a decrease of -9.62% compared to the previous year's 537.07 million. Earnings were 50.26 million, a decrease of -76.22%.

Financial Statements